NCT00004925View on ClinicalTrials.gov

Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 31, 1999

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions
Breast Cancer
Interventions
BIOLOGICAL

trastuzumab

DRUG

pegylated liposomal doxorubicin hydrochloride

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00004925 - Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter